Taiwan Treats Patient with New Cancer-Fighting Radiotherapy System from Elekta AB

STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: A patient with prostate cancer has received treatment using Elekta (STO:EKTAB) VMAT (Volumetric Modulated Arc Therapy) at the National Taiwan University Hospital (NTUH) in Taiwan. VMAT enables dramatically reduced treatment times and more precise targeting of tumors by simultaneously controlling all aspects of the treatment. It constantly changes the shape of the beam to conform to the shape of the area that needs to receive radiation while at the same time sparing the surrounding critical tissue. Like most organs, the prostate can move during treatment. By delivering radiation in less time, VMAT technology minimizes the opportunity for organ motion, which further enhances the precision of the radiation treatment.